Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: J Neurochem. 2011 Jun 6;118(2):237–247. doi: 10.1111/j.1471-4159.2011.07308.x

Figure 1.

Figure 1

The Csnk1δ/ε inhibitor PF-670462 (PF) dose-dependently blocks NAcc amphetamine (AMPH) induced locomotion. (A) Locomotor activity counts before and after NAcc AMPH (arrows) in three experiments each testing the indicated dose of PF (n/group=6-8). Insets show 60-minute total locomotor counts following AMPH (*, P<0.05, ***, P<0.001, vs Saline; ††, P<0.01, vs AMPH; Scheffé). (B) 60-minute total locomotor counts following NAcc saline or PF alone (n/group=6-7). (C) Injection cannula placements in the NAcc core. The numbers to the right indicate millimeters from bregma (Paxinos and Watson, 1997). Data are shown as mean±SEM.